View More Recent Stories

Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Dec 23, 2024 07:32AM Cytokinetics (CYTK) Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Dec 20, 2024 02:09PM Cytokinetics (CYTK) Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Dec 18, 2024 07:26AM Cytokinetics (CYTK) PT Raised to $82 at RBC Capital Following Bayer Partnership
Dec 3, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Dec 2, 2024 07:31AM Cytokinetics (CYTK) Announces FDA Acceptance of New Drug Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Nov 19, 2024 12:38PM Goldman Sachs Reiterates Neutral Rating on Cytokinetics (CYTK)
Nov 18, 2024 07:32AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Nov 11, 2024 07:32AM Cytokinetics (CYTK) Announces Initiation of Phase 1 Clinical Study of CK-4015089
Nov 6, 2024 04:01PM Cytokinetics (CYTK) Misses Q3 EPS by 13c
Oct 18, 2024 06:53AM Mizuho Reiterates Outperform Rating on Cytokinetics (CYTK)
Oct 17, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Oct 17, 2024 06:18AM Truist Securities Reiterates Buy Rating on Cytokinetics (CYTK)
Oct 9, 2024 07:20AM Cytokinetics (CYTK) PT Raised to $120 at H.C. Wainwright
Oct 1, 2024 06:56AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 30, 2024 07:24AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 20, 2024 06:49AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 9, 2024 12:11PM Goldman Sachs Reiterates Neutral Rating on Cytokinetics (CYTK)
Sep 9, 2024 07:30AM Cytokinetics (CYTK) Announces Data From Phase 1 Study of CK-4021586
Sep 9, 2024 06:41AM H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Sep 9, 2024 05:18AM BofA Securities Reiterates Neutral Rating on Cytokinetics (CYTK)
Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025
Sep 4, 2024 04:43PM Cytokinetics (CYTK) PT Raised to $71 at JPMorgan
Sep 4, 2024 06:40AM Mizuho Reiterates Outperform Rating on Cytokinetics (CYTK)
Sep 3, 2024 03:59PM Goldman Sachs Reiterates Neutral Rating on Cytokinetics (CYTK)
Aug 22, 2024 09:45AM Cytokinetics (CYTK) PT Raised to $92 at Jefferies
Aug 13, 2024 03:26AM Goldman Sachs Downgrades Cytokinetics (CYTK) to Neutral
Aug 7, 2024 10:00AM Eight defensive growth stocks to own right now
Jul 30, 2024 07:17AM RBC's biotech survey shows investors more bearish vs. last time
Jun 17, 2024 07:31AM Cytokinetics (CYTK) Announces Initiation of Phase 1 Study of Aficamten in Healthy Japanese Participants
Jun 10, 2024 06:24AM Piper Sandler Reiterates Overweight Rating on Cytokinetics (CYTK)
View More Recent Stories